These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35359401)

  • 1. Methylation of SPRED1: A New Target in Acute Myeloid Leukemia.
    Su N; Wang Y; Lu X; Xu W; Wang H; Mo W; Pang H; Tang R; Li S; Yan X; Li Y; Zhang R
    Front Oncol; 2022; 12():854192. PubMed ID: 35359401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Pilot Study of Aberrant CpG Island Hypermethylation of
    Sun J; Zhang J; Wang Y; Li Y; Zhang R
    Int J Med Sci; 2019; 16(2):324-330. PubMed ID: 30745814
    [No Abstract]   [Full Text] [Related]  

  • 3.
    Zhang R; Zhang Y; Lu X; Xu W; Wang H; Mo W; Pang H; Tang R; Li S; Yan X; Li Y
    Front Oncol; 2020; 10():204. PubMed ID: 32175275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between Spred1 and acute myeloid leukemia].
    Zhang Y; Li Y; Zhang R
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):1083-7. PubMed ID: 23998617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
    Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
    J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metallothionein III (MT3) is a putative tumor suppressor gene that is frequently inactivated in pediatric acute myeloid leukemia by promoter hypermethylation.
    Tao YF; Xu LX; Lu J; Cao L; Li ZH; Hu SY; Wang NN; Du XJ; Sun LC; Zhao WL; Xiao PF; Fang F; Li YH; Li G; Zhao H; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
    J Transl Med; 2014 Jun; 12():182. PubMed ID: 24962166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia.
    Tao YF; Fang F; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Li ZH; Wang NN; Xu LX; Du XJ; Sun LC; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
    BMC Cancer; 2015 Oct; 15():756. PubMed ID: 26490736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia.
    Sun GK; Tang LJ; Zhou JD; Xu ZJ; Yang L; Yuan Q; Ma JC; Liu XH; Lin J; Qian J; Yao DM
    Cancer Med; 2019 Oct; 8(14):6393-6402. PubMed ID: 31486300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc finger protein 382 is downregulated by promoter hypermethylation in pediatric acute myeloid leukemia patients.
    Tao YF; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Xu LX; Li ZH; Wang NN; Du XJ; Sun LC; Zhao H; Fang F; Su GH; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
    Int J Mol Med; 2014 Dec; 34(6):1505-15. PubMed ID: 25319049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The promoter of miR-663 is hypermethylated in Chinese pediatric acute myeloid leukemia (AML).
    Yan-Fang T; Jian N; Jun L; Na W; Pei-Fang X; Wen-Li Z; Dong W; Li P; Jian W; Xing F; Jian P
    BMC Med Genet; 2013 Jul; 14():74. PubMed ID: 23870168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermethylation of CpG sites at the promoter region is associated with deregulation of mitochondrial ATPsyn-β and chemoresistance in acute myeloid leukemia.
    Yang J; Xiao X; Li R; Li Z; Deng M; Zhang G
    Cancer Biomark; 2016; 16(1):81-8. PubMed ID: 26835708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter methylation of the candidate tumor suppressor gene TCF21 in myelodysplastic syndrome and acute myeloid leukemia.
    Gu Y; Zhou JD; Xu ZJ; Zhang TJ; Wen XM; Ma JC; Ji RB; Yuan Q; Zhang W; Chen Q; Lin J; Qian J
    Am J Transl Res; 2019; 11(6):3450-3460. PubMed ID: 31312357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DLX4 hypermethylation is a prognostically adverse indicator in de novo acute myeloid leukemia.
    Zhou JD; Zhang TJ; Wang YX; Yang DQ; Yang L; Ma JC; Wen XM; Yang J; Lin J; Qian J
    Tumour Biol; 2016 Jul; 37(7):8951-60. PubMed ID: 26753961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 5' flanking region of miR-378 is hypomethylated in acute myeloid leukemia.
    Zhu XW; Wen XM; Zhang YY; Yang L; Guo H; Yang J; Zhang M; Yin JY; Ma JC; Lin J; Deng ZQ; Qian J
    Int J Clin Exp Pathol; 2015; 8(5):4321-31. PubMed ID: 26191124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of GLIPR1 tumor suppressor as methylation-silenced gene in acute myeloid leukemia by microarray analysis.
    Xiao YH; Li XH; Tan T; Liang T; Yi H; Li MY; Zeng GQ; Wan XX; Qu JQ; He QY; Li JH; Chen Y; Xiao ZQ
    J Cancer Res Clin Oncol; 2011 Dec; 137(12):1831-40. PubMed ID: 21922325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and prognostic significance of ABO promotor methylation level in adult leukemia and myelodydysplastic syndrome].
    Shao M; Tang P; Lyu XP; Yang QK; Zhu WT; Jin HF; Wang L; Zhao XQ; Liu X; Sun L
    Zhonghua Nei Ke Za Zhi; 2018 Nov; 57(11):816-823. PubMed ID: 30392237
    [No Abstract]   [Full Text] [Related]  

  • 17. tp53-dependent G2 arrest mediator candidate gene, Reprimo, is down-regulated by promoter hypermethylation in pediatric acute myeloid leukemia.
    Tao YF; Li ZH; Wang NN; Fang F; Xu LX; Pan J
    Leuk Lymphoma; 2015; 56(10):2931-44. PubMed ID: 25629980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermethylation of ITGBL1 is associated with poor prognosis in acute myeloid leukemia.
    Lian XY; Ma JC; Zhou JD; Zhang TJ; Wu DH; Deng ZQ; Zhang ZH; Li XX; He PF; Yan Y; Lin J; Qian J
    J Cell Physiol; 2019 Jun; 234(6):9438-9446. PubMed ID: 30317626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Sprouty-related protein, Spred, inhibits cell motility, metastasis, and Rho-mediated actin reorganization.
    Miyoshi K; Wakioka T; Nishinakamura H; Kamio M; Yang L; Inoue M; Hasegawa M; Yonemitsu Y; Komiya S; Yoshimura A
    Oncogene; 2004 Jul; 23(33):5567-76. PubMed ID: 15184877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic methylation markers for overall survival in cytogenetically normal patients with acute myeloid leukemia treated on SWOG trials.
    Qu X; Othus M; Davison J; Wu Y; Yan L; Meshinchi S; Ostronoff F; Estey EH; Radich JP; Erba HP; Appelbaum FR; Fang M
    Cancer; 2017 Jul; 123(13):2472-2481. PubMed ID: 28222251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.